In neuroblastoma, STMN1 phosphorylation was reported to impact on metastasis by altering the levels of tyrosine-protein phosphatase non-receptor type 14 (PTPN14) [28] or in a tubulin-independent manner to enhance transendothelial migration via RhoA/ROCK signaling [29]. The gene discussed is RHOA; the disease is neuroblastoma.